OncoQuest starts dosing patients in Phase 3 trial of Oregovomab
Category: #health  By Saipriya Iyer  Date: 2020-11-11
  • sharesocial_share_icon
  • Twitter
  • Facebook
  • LinkedIn

OncoQuest starts dosing patients in Phase 3 trial of Oregovomab

Quest PharmaTech Inc., a Canadian biotechnology firm, has reportedly announced that OncoQuest Pharmaceuticals Inc., its South Korea-based majorly owned firm, has initiated the dosing of patients in USA as part of Phase 3 clinical trial of oregovomab, the company’s immunotherapeutic drug candidate. This global pivotal clinical study would be enrolling over 602 patients in 140 clinical sites spread across 17 nations.

The Phase 3 clinical study known as FLORA-5/GOG-3035, is a placebo-controlled, double blind, multicenter clinical trial to assess the efficacy and safety of oregovomab against placebo when given in combination with cycles of a six-cycle chemotherapy regimen to treat newly diagnosed patients with advance fallopian tube, epithelial ovarian or peritoneal carcinoma, together with maximum debulking surgical resection.

The secondary and primary endpoints, for both adjuvant and neoadjuvant cohorts of the study, are overall survival and progression free survival, respectively.

Meanwhile, the company also announced the appointment of Dr. Sunil Gupta as its new CMO (Chief Medical Officer). Dr. Gupta who is a MBBS, FRCPC possesses senior leadership experience of more than 30 years in clinical development, regulatory and medical affairs aimed at oncology drug development.   

Dr. Madi Madiyalakan, OncoQuest Pharmaceuticals Chairman, stated that the company is thrilled to welcome Dr. Gupta to the clinical development team as well as for initiating the Phase 3 study. The company is thankful to several individuals who helped it achieve this milestone, including its former Chief Medical Officer, Dr. Eliel Bayever.

In the US, the FLORA-5 Study is being conducted in partnership with the Gynecologic Oncology Group Foundation as well as IQVIA, a Connecticut based healthcare information technology company. Likewise, Greater China area clinical studies are being conducted in partnership with a Shenzhen Hepalink Pharmaceuticals Group Company named OncoVent. The Chinese company also has oregovomab’s commercialization license for the country.

Source credit: https://www.prnewswire.com/news-releases/quest-announces-that-oncoquest-pharmaceuticals-inc-doses-first-patient-in-phase-3-clinical-trial-flora-5-of-companys-lead-investigational-drug-oregovomab-in-frontline-ovarian-cancer-and-appoints-dr-sunil-gupta-as-chief-medi-301168187.html



About Author

Saipriya Iyer

Email: [email protected]   linkdin twitter

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

More News By Saipriya Iyer

 Tabletop Tape Dispensers  market valuation to surge at healthy CAGR through 2026

Tabletop Tape Dispensers market valuation to surge at healthy CAGR through 2026

By Saipriya Iyer

A comprehensive research study on Tabletop Tape Dispensers market added by Market Study Report provides insights into the market size and growth trends of this industry over the forecast timeline. The study evaluates key aspects of Tabletop Tape D...

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

By Saipriya Iyer

MarketStudyReport.com presents latest report on global General Well-Being Dietary Supplements Market, which evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The re...

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

By Saipriya Iyer

The report Eugenia Jambolana Extract market provides high-quality information regarding the major market trends, product types and their application scope, competitive landscape, and impact of COVID-19 outbreak.

.

Request a...